Psychiatric NP Scope of Practice for Insomnia in Michigan

If you’re a psychiatrist or PMHNP considering telehealth for insomnia care, you’re probably wondering: Can I legally prescribe controlled sleep medications like Ambien or temazepam to patients I’ve never seen in person?

The short answer in 2026: Yes — but with caveats that vary wildly by state.

The federal government has extended COVID-era flexibilities through December 31, 2026, allowing DEA-registered providers to prescribe Schedule II–V controlled substances via telehealth without an in-person exam. But here’s where it gets tricky: your state might impose additional restrictions on what you can prescribe, who can prescribe it (especially if you’re an NP), and whether insomnia even qualifies as a condition you can treat via telehealth.

This guide breaks down the federal telehealth prescribing landscape, explains how insomnia medications fit into controlled substance regulations, and walks through the rules in six key states where many telehealth providers practice: California, Texas, Florida, New York, Pennsylvania, and Illinois.

Federal Telehealth Prescribing: The Ryan Haight Act and DEA Extensions

The Pre-2020 Reality: In-Person Exams Were Mandatory

Before COVID, the Ryan Haight Online Pharmacy Act made it illegal to prescribe controlled substances via telemedicine without at least one in-person medical evaluation. The law was designed to shut down internet pill mills, but it also meant legitimate telehealth providers couldn’t prescribe any Schedule II–V medication — including common insomnia drugs like zolpidem (Ambien) or eszopiclone (Lunesta) — to new patients remotely.

If you were treating insomnia via telehealth pre-pandemic, you either had to:

• See the patient in person first, then manage refills via video
• Stick to non-controlled options like trazodone or melatonin agonists
• Refer patients elsewhere for controlled medications

COVID Changed Everything (Temporarily)

In March 2020, the DEA waived the in-person requirement. Suddenly, providers could prescribe controlled substances to new patients after a live audio-video telemedicine evaluation, as long as the prescription was for a legitimate medical purpose and complied with state law.

This waiver was supposed to be temporary. But the DEA has extended it repeatedly — most recently through December 31, 2026 — while they work on permanent regulations.

What this means for you now:
Through the end of 2026, you can prescribe Schedule IV insomnia medications (zolpidem, eszopiclone, temazepam, etc.) to patients you’ve only met via video, provided you meet the standard of care and comply with your state’s rules.

What Comes Next: Permanent DEA Telehealth Rules

The DEA has proposed a Special Registration framework to replace the temporary rules. Under this plan:

• Any DEA-registered provider could apply for a Telemedicine Special Registration to prescribe Schedule III–V controlled substances without an in-person exam
• Schedule II prescribing (stimulants, opioids) via telehealth would be limited to certain specialists — including psychiatrists — under an Advanced Telemedicine Registration
• A national PDMP (Prescription Drug Monitoring Program) would be implemented as a safeguard

These rules haven’t been finalized yet, but expect them before 2027. For now, the temporary flexibilities give you runway to build a telehealth insomnia practice — just stay alert for regulatory changes.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Insomnia Medications and Controlled Substance Schedules

Most prescription insomnia medications are Schedule IV controlled substances under federal law:

Non-benzodiazepine hypnotics (‘Z-drugs’):

• Zolpidem (Ambien)
• Eszopiclone (Lunesta)
• Zaleplon (Sonata)

Benzodiazepines:

• Temazepam (Restoril)
• Triazolam (Halcion)

Orexin receptor antagonists:

• Suvorexant (Belsomra)
• Lemborexant (Dayvigo)

Schedule IV means these drugs have accepted medical use but some potential for dependence. They’re considered lower-risk than Schedule II stimulants or opioids, which is why the DEA’s proposed telehealth rules would allow any registered provider to prescribe them under a special registration (not just specialists).

Non-controlled alternatives like trazodone (antidepressant), ramelteon (melatonin agonist), or doxepin (low-dose antidepressant) can be prescribed via telehealth without controlled-substance restrictions — but when insomnia is severe or hasn’t responded to these options, controlled hypnotics are often necessary.

Federal Requirements Still Apply

Even under the temporary DEA flexibilities, you must:

1. Maintain a DEA registration and authority to prescribe Schedule IV substances in the state where the patient is located
2. Meet the standard of care — your telehealth evaluation should be equivalent to an in-person exam (thorough sleep history, screening for medical causes like sleep apnea, assessment of psychiatric comorbidities)
3. Use your professional judgment — prescribe for legitimate medical purposes only, at the lowest effective dose and shortest duration
4. Follow state PDMP requirements — most states mandate checking the prescription monitoring database before prescribing controlled substances (more on this below)
5. Use electronic prescribing where required (many states now mandate EPCS for controlled substances)

The key principle: federal law sets the floor, but states can impose additional restrictions.

Psychiatrist vs. PMHNP Scope: Who Can Prescribe What?

Psychiatrists: Full Authority, Minimal Restrictions

As a physician (MD or DO), you have broad prescriptive authority under your medical license. Diagnosing and treating insomnia — including prescribing any controlled substances — is squarely within your scope of practice.

Key advantages:

• No supervision or collaboration requirements
• Full Schedule II–V prescribing authority in all states
• Can manage complex cases (insomnia co-occurring with depression, anxiety, etc.)
• Generally fewer telehealth restrictions compared to other provider types

The main regulatory considerations are the same as for any physician: maintain a state license where your patients are located, comply with DEA and state controlled substance laws, and meet the standard of care.

One thing to watch: some state medical boards have issued guidelines on safe prescribing of benzodiazepines and sedatives (usually in the context of preventing over-prescription or long-term use without appropriate monitoring). These aren’t typically binding laws, but following them helps protect your license.

PMHNPs: It Depends on Your State

Psychiatric-Mental Health Nurse Practitioners can assess, diagnose, and treat insomnia — but your ability to prescribe controlled sleep medications independently varies dramatically by state.

States fall into three categories:

Full Practice Authority (FPA) States:NPs can practice and prescribe independently after meeting experience requirements.

• New York: After 3,600 hours of practice under a collaborative agreement (~2 years full-time), you can practice independently
• Illinois: After 4,000 hours and additional training, you can obtain FPA and prescribe controlled substances without physician oversight
• California: AB 890 created a pathway for experienced NPs to practice independently; by 2026, many PMHNPs are operating solo practices

Reduced Practice States:NPs can prescribe but need a collaborative agreement with a physician.

• Pennsylvania: You must have a written collaborative agreement with a physician to prescribe any medications, including controlled substances
• New York (for new NPs): Until you hit that 3,600-hour threshold, you need a physician collaboration

Restricted Practice States:NPs require direct supervision or significant physician oversight.

• Texas: You need a Prescriptive Authority Agreement with a supervising physician. You cannot prescribe Schedule II controlled substances in outpatient settings at all — but Schedule IV insomnia meds are allowed under physician delegation
• Florida: PMHNPs require a supervising physician’s protocol. (A 2020 law created autonomous practice for some APRNs, but excluded psychiatric NPs; legislation to change this is pending as of 2025)

The practical impact:
If you’re an experienced PMHNP in New York or Illinois, you can run a solo telehealth insomnia practice and prescribe Ambien or other Schedule IV medications independently. In Texas or Florida, you’ll need a collaborating physician — which doesn’t mean they co-sign every prescription, but they must provide oversight and be available for consultation.

For telehealth companies like Klarity, this means:

• In FPA states, recruiting independent NPs is straightforward
• In restricted states, you need physician oversight infrastructure in place

State-Specific Telehealth Prescribing Rules

Here’s where things get complicated. Let’s walk through the rules in six priority states, focusing on what actually matters for insomnia care.

California: Permissive on Telehealth, Evolving NP Independence

Licensure: You must hold a California license (no special telehealth license available). CA is not in the Interstate Medical Licensure Compact, so out-of-state psychiatrists need to go through full licensure.

NP Scope: AB 890 (implemented 2023) allows experienced NPs to practice independently. After three years under physician oversight, you can qualify as a ‘104 NP’ and practice solo, including prescribing controlled substances.

Telehealth Prescribing Rules:

• No state-level prohibition on tele-prescribing Schedule IV insomnia medications
• Schedule II controlled substances shouldn’t be prescribed solely via telehealth without an in-person exam (this is based on older board guidance aimed at preventing internet prescribing of stimulants and opioids)
• The standard: telehealth exam must be equivalent to in-person care

PDMP Requirements:You must check California’s CURES database before prescribing any Schedule II–IV controlled substance for the first time to a patient, and at least every four months if therapy continues. Electronic prescribing is mandatory for all controlled substances (with limited exceptions).

Local Market:High demand for mental health care, especially in rural areas. Strong telehealth parity laws mean Medi-Cal and private insurers cover telehealth at the same rate as in-person. Large, diverse population means opportunities for Spanish-speaking or Mandarin-speaking providers.

Bottom line: CA is telehealth-friendly. Just ensure your telehealth exam meets the standard of care, check CURES before prescribing, and use e-prescribing.

Texas: Favorable for Telehealth, Restrictive for NPs

Licensure: Texas is in the IMLC (Interstate Medical Licensure Compact), which expedites physician licensure. APRNs need a Texas license and supervising physician.

NP Scope: Restricted practice. PMHNPs need a written Prescriptive Authority Agreement with a Texas physician. Cannot prescribe Schedule II controlled substances in outpatient settings (only Schedule III–V with delegation).

Telehealth Prescribing Rules:Here’s the critical exception: Texas prohibits using telemedicine to treat chronic pain with controlled substances. This is meant to prevent opioid abuse via pill mills.

But here’s the key: insomnia is not ‘chronic pain.’

You can legally prescribe Schedule IV insomnia medications via telehealth in Texas — just ensure it’s documented as insomnia treatment, not pain management. If a patient also has chronic pain, avoid prescribing sedatives ‘for pain’ via telehealth.

PDMP Requirements:Mandatory check of Texas PMP AWARxE before prescribing opioids, benzodiazepines, barbiturates, or carisoprodol. As of September 2021, Texas added all Schedule III–V drugs to the mandatory-check list, so you must run a PMP check before prescribing zolpidem or any other Schedule IV sleep medication.

Electronic prescribing is mandatory for all controlled substances.

Local Market:Large patient pool (urban centers plus vast rural areas), high prevalence of insomnia, strong telehealth adoption post-2017 reforms. The need for physician supervision of NPs can be a barrier to scaling NP-led care, but psychiatrists have an edge in independence.

Bottom line: Texas is telehealth-friendly for psychiatrists. NPs need physician collaboration. The ‘chronic pain via telehealth’ prohibition doesn’t apply to insomnia — just document appropriately and check the PDMP religiously.

Florida: Telehealth-Friendly for Mental Health, NP Restrictions Remain

Licensure: Florida has a unique Out-of-State Telehealth Provider Registration program — you can register to practice in FL without full licensure if you hold an unrestricted license in another state. This makes multi-state telehealth easier.

NP Scope: Restricted practice for PMHNPs. A 2020 law created autonomous practice for some primary care APRNs, but excluded psychiatric NPs. Legislation to change this is pending (SB 758 proposed in 2025), but as of early 2026, PMHNPs still need a supervising psychiatrist or physician.

Telehealth Prescribing Rules:Florida law prohibits prescribing controlled substances via telehealth — except for treatment of:

1. Psychiatric disorders
2. Inpatient hospital care
3. Hospice care
4. Nursing home residents

Here’s the critical point for insomnia: Insomnia disorder is classified as a mental health condition (it’s in the DSM-5). As long as you’re treating insomnia as a psychiatric disorder, you can prescribe Schedule IV sleep medications via telehealth legally.

Document this carefully. Note the psychiatric nature of the insomnia (e.g., ‘Insomnia Disorder, DSM-5 code 780.52’ or note comorbid anxiety/depression). Avoid framing it purely as a ‘medical’ condition if you’re prescribing controlled substances via telehealth.

PDMP Requirements:You must check Florida’s E-FORCSE database before prescribing any controlled substance to a patient age 16 or older, and for each new prescription.

Local Market:Large elderly population with high insomnia prevalence, significant snowbird population that values telehealth access. Regulators remain cautious after past telemedicine controversies, so maintain meticulous documentation.

Bottom line: Florida allows telehealth prescribing of insomnia medications under the ‘psychiatric disorder’ exception. Just ensure clinical documentation reflects the mental health nature of the treatment. NPs need physician oversight. Out-of-state providers can leverage the telehealth registration program.

New York: Progressive NP Laws, Strong Telehealth Support

Licensure: Must hold a New York license (no special telehealth license). Not in the IMLC, so out-of-state psychiatrists need full licensure.

NP Scope: Full Practice Authority after 3,600 hours of practice (about 2 years full-time) under a collaborative agreement. After that, you can practice independently — no physician oversight required. Made permanent in 2022.

Telehealth Prescribing Rules:No state-level restrictions on prescribing controlled substances via telehealth beyond federal requirements. If you meet the standard of care via telehealth, you can prescribe.

PDMP Requirements:Mandatory check of New York’s I-STOP PDMP before every prescription of Schedule II, III, or IV controlled substances. This is stricter than many states — you must check each time you write a new prescription, not just the first time.

Electronic prescribing is required for all medications (with very limited exceptions).

Local Market:NYC and suburbs have high provider concentration but also massive demand (long waitlists for psychiatrists). Upstate New York faces provider shortages, making telehealth valuable. Strong government and insurer support for telehealth, including Medicaid coverage.

Bottom line: NY is highly permissive for telehealth, especially for mental health. Experienced PMHNPs can operate independent practices. Just ensure strict PDMP compliance — New York monitors controlled substance prescribing aggressively.

Pennsylvania: Standard Telehealth, NP Collaboration Required

Licensure: PA is in the IMLC for physicians. No special telehealth license yet (comprehensive telehealth legislation has been attempted but not passed).

NP Scope: Reduced practice. PMHNPs must have a collaborative agreement with a physician to prescribe any medications, including controlled substances. No independent practice yet.

Telehealth Prescribing Rules:No additional state barriers beyond federal requirements. The PA Medical Board accepts that provider-patient relationships can be established via telehealth if standard of care is met.

PDMP Requirements:You must check Pennsylvania’s ABC-MAP PDMP before initially prescribing any opioid or benzodiazepine, and for every subsequent refill/prescription of opioids or benzos. This is one of the stricter PDMP laws nationally.

For insomnia: if you’re prescribing a benzodiazepine like temazepam or lorazepam for sleep, you must check the PDMP each time. For non-benzo hypnotics like zolpidem, checking isn’t legally mandated but is strongly encouraged (and most systems default to checking for all controlled substances).

Local Market:Mix of urban (Philadelphia, Pittsburgh) and large rural areas with limited psychiatrist access. Telehealth expansion has been a focus, especially for mental health in rural PA.

Bottom line: PA is straightforward — follow federal rules, check the PDMP for benzos, and ensure NPs have collaborating physicians on record. No unique telehealth barriers, but also no independent NP practice yet.

Illinois: Progressive NP Laws, Telehealth-Friendly

Licensure: Illinois is in the IMLC for physicians. APRNs need Illinois license (not in APRN Compact).

NP Scope: Full Practice Authority available. After 4,000 hours of clinical experience and additional training, NPs can apply for FPA, allowing independent practice and prescribing (including controlled substances) without physician collaboration.

NPs without FPA still need a collaborative agreement but can prescribe Schedule III–V (and limited Schedule II if specifically delegated).

Telehealth Prescribing Rules:No state-specific restrictions. Illinois law requires a proper patient examination (telehealth counts) and legitimate medical purpose. The 2021 Telehealth Act update made many COVID-era flexibilities permanent, including audio-only for mental health and parity protections.

PDMP Requirements:Providers must attempt a PDMP check before prescribing controlled substances. As of 2018, this is mandatory for opioids initially. It’s not strictly mandatory for all Schedule IV, but strongly encouraged. Electronic prescribing of controlled substances became mandatory in 2023.

Local Market:Chicago area has high provider density but also high demand. Downstate Illinois faces provider shortages, creating opportunities for telehealth specialists. Strong insurer support for telehealth, including Medicaid.

Bottom line: Illinois is one of the most provider-friendly states for telehealth insomnia care. FPA NPs can operate independently, telehealth is well-integrated into the healthcare system, and regulations focus on opioid safety (not particularly restrictive for insomnia medications).

The Economics: Why Telehealth Platforms Make Sense

Here’s where the business case becomes clear.

Building a solo telehealth insomnia practice sounds appealing — set your own schedule, see patients from anywhere, no office overhead. But the economics are tougher than they appear.

The hidden costs of DIY patient acquisition:

SEO (Search Engine Optimization):

• Takes 6–12 months of consistent investment before generating meaningful patient flow
• Requires ongoing content creation, technical optimization, and often hiring an agency ($1,500–$5,000+/month)
• Most solo providers don’t have the expertise or patience for this

Google Ads:

• Mental health keywords cost $15–$40+ per click
• Most clicks don’t convert to booked patients
• A realistic cost per booked patient through PPC is $200–$400+ when you factor in testing, optimization, and no-shows

Directory Listings:

• Psychology Today, Zocdoc, and similar platforms charge monthly fees ($30–$150+/month)
• You’re competing with hundreds of other providers on the same page
• Zocdoc charges per booking ($35–$100+), and when you add subscription costs, total monthly expenses add up fast

The all-in reality:When you factor in agency/consultant fees, ad spend testing and optimization, staff time to handle and qualify leads, no-show rates from cold leads, and failed campaigns, acquiring a qualified psychiatric patient through DIY marketing typically costs $200–$500+ — and that’s per patient, not per appointment.

For a solo provider trying to fill a schedule with 20–30 patients/week, you’re looking at $3,000–$5,000+/month in marketing spend with uncertain ROI.

The platform alternative:

Klarity Health uses a pay-per-appointment model (similar to Zocdoc) where providers pay a standard listing fee per new patient lead. The value proposition:

• No upfront marketing spend or monthly subscription fees
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs like Doxy.me or SimplePractice subscriptions)
• Both insurance and cash-pay patient flow through one platform
• You control your schedule — only pay when you see patients

Instead of gambling $3,000–$5,000/month on marketing channels that might generate patients, you pay only when a qualified patient actually books with you. That’s guaranteed ROI vs. speculative marketing investment.

When DIY makes sense:If you have the budget, expertise, and patience — and especially if you’re in a niche with low competition — DIY marketing can eventually be cost-effective. But for most providers, especially those starting out or scaling, a platform that handles patient acquisition removes the risk entirely.

Compliance Best Practices (Regardless of State)

1. Check Your State’s PDMP Before PrescribingMost states mandate this for controlled substances. Even if your state doesn’t require it for Schedule IV, check anyway — it protects you from inadvertently prescribing to someone who’s doctor-shopping or has a substance use disorder you weren’t aware of.

2. Document ThoroughlyYour telehealth encounter note should include:

• Sleep history (onset, duration, frequency of insomnia)
• Screen for medical causes (sleep apnea, restless legs, medication side effects)
• Psychiatric assessment (depression, anxiety, PTSD — all common comorbidities)
• Prior treatments tried (behavioral interventions, OTC meds)
• Rationale for controlled medication (e.g., ‘Patient has failed sleep hygiene modifications and trazodone; starting zolpidem 5mg for short-term relief while coordinating CBT-I referral’)

This documentation protects you if a medical board ever questions your prescribing.

3. Educate Patients on RisksDiscuss dependency potential, avoid long-term use without reassessment, and document the conversation. Many states expect providers to obtain informed consent for controlled substance treatment.

4. Use the Lowest Effective Dose for the Shortest DurationStart with 5mg zolpidem, not 10mg. Prescribe a 2-week supply initially, not 90 days. This aligns with clinical best practices and regulatory expectations.

5. Consider Behavioral InterventionsPrescribing a sleep medication alone isn’t the standard of care for chronic insomnia. The gold standard is CBT-I (Cognitive Behavioral Therapy for Insomnia). You don’t have to provide it yourself, but recommend it, coordinate a referral, or at minimum discuss sleep hygiene.

6. Stay Updated on Regulatory ChangesThe DEA is finalizing permanent telehealth rules. Your state might pass new legislation (like Florida’s pending psych NP autonomy bill). Subscribe to your state medical/nursing board updates and DEA announcements.

FAQ: Telehealth Prescribing for Insomnia

Can I prescribe Ambien to a patient I’ve never met in person?
Yes, through December 31, 2026, under federal DEA flexibilities. After that, you’ll likely need a special DEA telemedicine registration (proposed rules). State laws may impose additional restrictions.

Do I need to check the PDMP every time I prescribe a sleep medication?
It depends on your state. New York and Pennsylvania require checks for every benzodiazepine prescription. California requires checks before the first Schedule II–IV prescription and every four months. Texas requires checks for all Schedule III–V. Even if not required, checking is best practice.

Can PMHNPs prescribe controlled sleep medications via telehealth?
Yes, if your state allows NP prescribing of controlled substances. In Full Practice Authority states (NY after 3,600 hours, Illinois with FPA), you can prescribe independently. In Reduced/Restricted Practice states (TX, FL, PA), you need physician collaboration or supervision.

What if my patient lives in a different state than where I’m licensed?
You must be licensed in the state where the patient is located at the time of the telehealth visit. There’s no federal telehealth license. Some states (like Florida) offer telehealth registration for out-of-state providers, and compacts like the IMLC can expedite multi-state licensure for physicians.

Does the Ryan Haight Act still apply during the DEA extension?
The in-person exam requirement has been waived through December 2026. But you still must meet all other Ryan Haight requirements: valid DEA registration, legitimate medical purpose, state law compliance, etc.

What happens if I prescribe a controlled substance via telehealth in a state that prohibits it?
You could face state medical board discipline, DEA sanctions, or even criminal charges. Always verify your state’s specific rules. For example, Texas prohibits controlled substances via telehealth for chronic pain (but insomnia is allowed). Florida prohibits it except for psychiatric treatment (insomnia qualifies).

Can I use audio-only (phone) for insomnia consultations?
Federal law currently requires audio-video for most controlled substance prescribing via telehealth (though audio-only is permitted for buprenorphine in opioid use disorder treatment). Some states allow audio-only for mental health follow-ups. Check your state’s rules and ensure you can meet the standard of care via phone.

Next Steps: Building a Compliant Telehealth Insomnia Practice

If you’re a psychiatrist:

1. Ensure you’re licensed in every state where you’ll see patients
2. Obtain DEA registration in those states (you need a separate DEA number for each state where you maintain a practice location, but if you’re purely telehealth, your primary state DEA number + state medical licenses generally suffice — verify with DEA)
3. Set up PDMP access in each state
4. Implement EPCS (electronic prescribing of controlled substances)
5. Develop intake templates that capture the documentation required for controlled substance prescribing
6. Consider whether you’ll handle patient acquisition yourself (SEO, ads, directories) or join a platform that provides qualified leads

If you’re a PMHNP:

1. Verify your state’s scope of practice laws — do you have Full Practice Authority, or do you need a collaborating physician?
2. If collaboration is required, establish a written agreement with a physician that explicitly covers controlled substance prescribing
3. Follow the same DEA, PDMP, and EPCS steps as above
4. If you’re in a Reduced Practice state, ensure your collaborating physician is comfortable with telehealth insomnia care and controlled substance management
5. Advocate for scope expansion if your state is considering NP independence legislation (like Florida’s pending psych APRN bill)

For both:

The path of least resistance for most providers isn’t building a solo practice from scratch — it’s joining a platform that handles patient acquisition, credentialing, telehealth infrastructure, and compliance documentation.

Klarity Health offers:

• Pre-qualified insomnia patients matched to your availability
• Built-in telehealth platform (HIPAA-compliant, integrated prescribing)
• No monthly fees or upfront marketing costs — you pay only when you see patients
• Support for both insurance and cash-pay patients
• Credentialing assistance for multi-state licensure

Instead of spending months building a patient pipeline and thousands on marketing that may not convert, you can start seeing patients immediately and focus on what you do best: providing excellent clinical care.

Ready to explore joining Klarity’s provider network? Visit [Klarity’s provider page] to learn more about how we support psychiatrists and PMHNPs building telehealth practices — without the marketing headaches.

Sources and References

1. DEA Press Release – ‘DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care’ (December 31, 2025). Official announcement of the Fourth Temporary Extension through December 31, 2026. www.dea.gov

2. DEA Press Release – ‘DEA Announces Three New Telemedicine Rules to Continue Open Access to Care’ (January 16, 2025). Details on proposed Special Registration framework and permanent telehealth rules. www.dea.gov

3. Healthcare Finance News – ‘Telehealth prescribing of controlled drugs extended through 2025’ by Susan Morse (November 18, 2024). Analysis of DEA extensions and context on Ryan Haight Act waivers. www.healthcarefinancenews.com

4. Florida Statutes §456.47 – Use of Telehealth to Provide Services. Official state law defining telehealth practice and controlled substance prescribing limitations (psychiatric disorder exception). www.leg.state.fl.us

5. New York State Education Department – Practice Requirements for Nurse Practitioners. Official guidance on NY NP collaborative practice requirements and 3,600-hour independence threshold. www.op.nysed.gov

Source:

• https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care#:~:text=WASHINGTON%20%E2%80%93%C2%A0The%20U,flexibilities%20through%20December%2031%2C%202026
• https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care#:~:text=Under%20these%20telemedicine%20flexibilities%2C%20DEA,applicable%20federal%20and%20state%20law
• https://www.healthcarefinancenews.com/news/telehealth-prescribing-controlled-drugs-extended-through-2025#:~:text=During%20the%20COVID,person%20evaluation%20of%20that%20patient
• https://www.dlapiper.com/en-th/insights/publications/2024/11/dea-and-hhs-issue-third-temporary-extension-of-telemedicine-flexibilities#:~:text=Further%2C%20as%20the%20Third%20Temporary,monitor%20this%20space%20for%20updates
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=ever%20having%20an%20in,specialized%20medical%20providers%20to%20issue
• https://www.op.nysed.gov/professions/nurse-practitioners/professional-practice/practice-requirements#:~:text=New%20York%20State%20Education%20Law,to%20practice%20under%20physician%20supervision
• https://idfpr.illinois.gov/profs/nursing.html#:~:text=,APN%20Controlled%20Substance
• https://www.op.nysed.gov/professions/nurse-practitioners/professional-practice/practice-requirements#:~:text=Nurse%20practitioners%2C%20however%2C%20must%20practice,or%20certified%20NP%20as%20follows
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=also%20are%20psychiatric%20nurses%20as,455
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=provider%20may%20not%20use%20telehealth,in%20Schedule%20II%20of%20s